RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationMHRA shares findings from its pilot to improve how substantial clinical trial modifications are handled.
A new OpenAI model aims to speed up biology and drug development research while keeping scientists firmly in control.
Insights from the National AI Commission addressing key questions on AI’s future in the UK.
How regulatory innovation and collaboration are driving the future of healthcare.
MHRA guidance outlining who is responsible for what in UK clinical trials.
Key discussions and performance updates from MHRA’s annual accountability review.
MHRA highlights how organisations can embrace AI and emerging technologies in regulated environments.
Available to view now.
EMA would like to inform you of the publication of a new document of frequently asked questions (FAQ) for sponsors on the Clinical Trials Information System (CTIS).
Out now